122 related articles for article (PubMed ID: 1712347)
1. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence.
Möller P; Koretz K; Schlag P; Momburg F
Int J Cancer Suppl; 1991; 6():155-62. PubMed ID: 1712347
[TBL] [Abstract][Full Text] [Related]
2. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
3. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
4. Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.
Koretz K; Schlag P; Möller P
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):389-94. PubMed ID: 1721470
[TBL] [Abstract][Full Text] [Related]
5. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma-induced expression of HLA-DR and LFA-3 was enhanced by cryopreservation.
Lee MC; Ono M; Nakajima J; Kawauchi M; Kotsuka Y; Takamoto S; Furusa A
Transplant Proc; 1998 Nov; 30(7):2964-5. PubMed ID: 9838308
[No Abstract] [Full Text] [Related]
7. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation.
Momburg F; Möller P; Moldenhauer G; Hämmerling GJ
J Immunogenet; 1986; 13(2-3):195-9. PubMed ID: 3469275
[TBL] [Abstract][Full Text] [Related]
8. Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens.
Favrot MC; Combaret V; Goillot E; Tabone E; Bouffet E; Dolbeau D; Bouvier R; Coze C; Michon J; Philip T
Int J Cancer; 1991 Jun; 48(4):502-10. PubMed ID: 1710608
[TBL] [Abstract][Full Text] [Related]
9. Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
Stein B; Momburg F; Schwarz V; Schlag P; Moldenhauer G; Möller P
Br J Cancer; 1988 Apr; 57(4):364-8. PubMed ID: 2839218
[TBL] [Abstract][Full Text] [Related]
10. [HLA antigens in patients with laryngeal cancer].
Beleites B; Wegener S; Nowak R; Wilden G
Laryngol Rhinol Otol (Stuttg); 1988 Oct; 67(10):543-4. PubMed ID: 3236988
[TBL] [Abstract][Full Text] [Related]
11. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
[TBL] [Abstract][Full Text] [Related]
12. HLA-A,B,C, and DR antigens in recurrent oral ulcers.
Albanidou-Farmaki E; Kayavis IG; Polymenidis Z; Papanayotou P
Ann Dent; 1988; 47(1):5-8, 15. PubMed ID: 3178134
[No Abstract] [Full Text] [Related]
13. Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
Durrant LG; Ballantyne KC; Armitage NC; Robins RA; Marksman R; Hardcastle JD; Baldwin RW
Br J Cancer; 1987 Oct; 56(4):425-32. PubMed ID: 3689659
[TBL] [Abstract][Full Text] [Related]
14. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between HLA-DR antigen expression and CD4 positive lymphocytic populations in normal mucosa, tubulovillous adenoma, and invasive carcinoma of the colon.
Tamiolakis D; Venizelos I
Cesk Patol; 2006 Apr; 42(2):52-8. PubMed ID: 16715627
[TBL] [Abstract][Full Text] [Related]
16. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.
Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R
Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974
[TBL] [Abstract][Full Text] [Related]
17. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
18. Transfection of HLA-DR-expressing DAP.3 cells with a cDNA clone encoding the glycosyl phosphatidylinositol-linked form of lymphocyte function associated antigen-3: biochemical features and functional consequences.
Greenlaw R; Robinson P; Heaton T; Lombardi G; Lechler R
Int Immunol; 1992 Jun; 4(6):673-80. PubMed ID: 1377490
[TBL] [Abstract][Full Text] [Related]
19. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
